Ina Kenji, Furuta Ryuichi, Kataoka Takae, Nishio Tomoko, Nagao Seiji, Kayukawa Satoshi, Masaki Ayako, Ando Takafumi, Goto Hidemi
Dept. of Medical Oncology, Nagoya Memorial Hospital, Japan.
Gan To Kagaku Ryoho. 2009 Jun;36(6):979-81.
Two unresectable advanced gastric cancer cases with peritoneal metastases were successfully treated by the combination therapy of S-1 and paclitaxel. S-1 (1.25m(2): 80 mg/day, 1.25m(2)-1.50m(2)<:120 mg/day) was administered orally for 14 consecutive days followed by 14 days rest and a 2-hour infusion of paclitaxel (50 mg/m(2)) was administered on day 1 and 15 of each course. Treatment was repeated every 4 weeks unless disease progression or severe adverse effects were observed. Case 1: 65-year-old male (performance status: PS 3) with type 1 gastric cancer with malignant ascites. Case 2: 66-year-old male (PS3) with peritoneal metastases whose primary gastric lesion was surgically resected. Partial response was obtained in the former and complete response in the latter. Combination therapy of S-1 and paclitaxel can be highly recommended for patients with inoperable gastric cancer with poor PS.
两例伴有腹膜转移的不可切除进展期胃癌患者通过S-1与紫杉醇联合治疗获得成功。S-1(体表面积1.25m²:80毫克/天,体表面积1.25m²至1.50m²:120毫克/天)连续口服14天,随后休息14天,在每个疗程的第1天和第15天静脉滴注2小时紫杉醇(50毫克/平方米)。每4周重复治疗,除非观察到疾病进展或出现严重不良反应。病例1:一名65岁男性(体力状况:PS 3),患有1型胃癌并伴有恶性腹水。病例2:一名66岁男性(PS3),有腹膜转移,其原发性胃部病变已手术切除。前者获得部分缓解,后者获得完全缓解。对于PS较差的不可手术胃癌患者,强烈推荐S-1与紫杉醇联合治疗。